MPC vs PRLD · P/E 16, rev $138.86B vs rev $6.5M
Marathon Petroleum Corp (MPC) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
MPC currently screens at market cap $71.41B and trailing P/E 16.1. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the MPC and PRLD stock pages for the full models.
Not investment advice.